News report 📈 Stocks 🌍 United States

IBEX Posts 6th Consecutive Quarter of Double-Digit Revenue Growth

IBEX shares gain momentum as the company leverages AI-agent deployments to capture market share from traditional BPO competitors and expand its high-margin HealthTech footprint.

📅 September 11, 2026 🕐 1 min read

1 assets impacted (Stocks). Net bias: 1 Bullish, 0 Bearish, 0 Neutral. Strongest signal: IBEX ↑ 8/10 (68% confidence).

📊 Affected Assets (1)

IBEX

Bullish 🤖 68%

📅 Short-term 🌍 US · Explicit

IBEX reported strong Q4 2026 earnings with double-digit revenue growth, AI-driven market share gains, and positive guidance, boosting investor confidence.

🎯 Key Takeaways

Achieved six consecutive quarters of double-digit revenue growth.
HealthTech vertical revenue reached $114 million through organic expansion.
AI agents now handle 20% to 40% of call volume, acting as a growth vector rather than a cannibalization risk.
Management projects FY27 revenue growth of 9% to 11% with expanding EBITDA margins.

📝 Executive Summary

IBEX reported strong Q4 2026 results, highlighted by double-digit revenue growth and a successful pivot toward AI-driven service models. The company surpassed $114 million in its HealthTech vertical and expects FY27 revenue growth between 9% and 11% as AI agents accelerate client onboarding.

❓ FAQ

How is IBEX utilizing AI to differentiate itself from traditional BPO competitors?

IBEX uses AI agents to handle 20% to 40% of call volume, allowing for immediate scale that would otherwise take months of human training. This technology acts as a 'Trojan horse' to win new contracts and capture market share from incumbents.

📰 Related Articles

🏷️ Tags

📰 Source

🔗 View Original Article